Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine Effect on Gastric Residual Volume
NCT05342818Phase 2Completed
- Sponsor
- Tanta University
- Start
- Apr 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of neostigmine in gastroparesis, sponsored by Tanta University. Started Apr 2022; status: completed.
02
Drugs
neostigmine
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT05342818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05342818.